Skip to main content

Table 5 Participants’ preferences for allocation criteria (Separating cohorts 1 and 2)

From: Public preferences regarding the priority setting criteria of health interventions for budget allocation: results of a survey of Iranian adults

Criteria

Cohort

Choice

Proportion (CI)%

Prioritize Group 1

Equal Allocation

Prioritize Group 2

Disease severity

1

No Trade-off

61.9 (57.5-66.1)

24.6 (21-28.6)

13.4 (10.6-16.7)

Effectiveness trade-off

33.8 (29.7-38.1)

29.9 (26.03-34.15)

36.25 (32.1-40.6)

OR = 0.314; p = 0.001

OR = 1.306; p = 0.062

OR = 3.662; p = 0.001

2

No Trade-off

61.3 (56.8-65.6)

22.7 (19.1-26.7)

15.9 (12.8-19.5)

Effectiveness trade-off

54.9 (50.4-59.4)

28.4 (24.5-32.7)

16.5 (13.4-20.2)

OR = 0.769; p = 0.047

OR = 1.352; p = 0.043

OR = 1.047; p = 0.791

Age (Children or Adults)

1

No Trade-off

50.1 (45.6-54.5)

43.7(39.4-48.2)

6.1(4.2-8.6)

Effectiveness trade-off

28.9 (25.06-33.1)

37.8 (33.6-42.2)

33.1 (29.1-37.5)

OR = 0.405; p = 0.001

OR = 0.782; p = 0.059

OR = 7.636; p = 0.001

2

No Trade-off

53.2 (48.7-57.7)

38.4 (34.1-42.9)

8.2 (6.1-11.1)

cost trade-off

61.3 (56.8-65.6)

30.9 (26.9-35.3)

7.6 (5.5-10.4)

OR = 1.391; p = 0.012

OR = 0.719; p = 0.016

OR = 0.916; p = 0.718

Daily care Needs

1

No Trade-off

55.6 (51.1-59.9)

28.3 (24.4-32.4)

16.08 (13.08-19.6)

Effectiveness trade-off

35.03 (30.9-39.3)

27.6 (23.9-31.8)

37.2 (33.08-41.6)

OR = 0.430; p = 0.001

OR = 0.97; p = 0.831

OR = 3.098; p = 0.001

2

No Trade-off

53.9 (49.3-58.4)

32.6 (28.5-37.08)

13.3 (10.5-16.7)

cost trade-off

49.4 (44.9-53.9)

33.3 (29.2-37.7)

17.1 (14.04-20.8)

OR = 0.836; p = 0.1709

OR = 1.029; p = 0.835

OR = 1.345; p = 0.1032

Access to Alternative Interventions

1

No Trade-off

58.6 (54.2-62.9)

29.3 (25.4-33.5)

12.01 (9.4-15.2)

Effectiveness trade-off

42.1 (37.8-46.5)

28.7 (24.8-32.8)

29.1 (25.2-33.3)

OR = 0.513; p = 0.001

OR = 0.97; p = 0.832

OR = 3.008; p = 0.001

2

No Trade-off

55.8 (51.3-60.2)

29.9 (25.9-34.2)

14.2 (11.3-17.6)

cost trade-off

69.6 (65.3-73.6)

20.1 (16.7-24.05)

10.1 (7.7-13.2)

OR = 1.814; p = 0.001

OR = 0.591; p = 0.0005

OR = 3.684; p = 0.058

Individual’s Economic status

1

No Trade-off

78 (74.1-81.4)

17.3 (14.2-20.9)

4.6 (3.1-6.9)

Effectiveness trade-off

57.4 (52.9-61.7)

24.8 (21.2-28.8)

17.7 (14.5-21.3)

OR = 0.380; p = 0.001

OR = 1.579; p = 0.003

OR = 4.381; p = 0.001

2

No Trade-off

76 (71.9-79.6)

16.9 (13.8-20.6)

7 (5.01-9.7)

cost trade-off

77.9 (73.9-81.4)

15.9 (12.8-19.5)

6.1 (4.3-8.7)

OR = 1.113; p = 0.486

OR = 0.925; p = 0.66

OR = 0.870; p = 0.599

Population Size (Common or Rare Diseases)

1

No Trade-off

37.4 (33.2-41.8)

30.9 (27.01-35.2)

31.5 (27.5-35.8)

Effectiveness trade-off

31.3 (27.3-35.6)

25.8 (22.1-29.9)

42.7 (38.4-47.2)

OR = 0.762; p = 0.0439

OR = 0.778; p = 0.076

OR = 1.62; p = 0.0003

2

No Trade-off

47.7 (43.2-52.3)

27.3 (23.5-31.6)

24.8 (21.1-28.9)

cost trade-off

53.2 (48.7-57.7)

22.7 (19.1-26.7)

23.9 (20.3-28.07)

OR = 1.247; p = 0.0902

OR = 0.779; p = 0.098

OR = 0.955; p = 0.761

Diseases with Absence from work

1

No Trade-off

66.1 (61.8-70.2)

23.6 (20.06-27.6)

10.1 (7.7-13.1)

Effectiveness trade-off

41.3 (37.05-45.7)

27.08 (23.3-31.2)

31.5 (27.5-35.8)

OR = 0.360; p = 0.001

OR = 1.201; p = 0.212

OR = 4.068; p = 0.001

2

No Trade-off

73.03 (68.8-76.8)

19.5 (16.1-23.3)

7.4 (5.3-10.1)

cost trade-off

71.3 (67.07-75.2)

21.4 (17.9-25.3)

7.2 (5.1-9.9)

OR = 0.918; p = 0.560

OR = 1.124; p = 0.467

OR = 0.969; p = 0.9005

Lifestyle-related diseases

1

No Trade-off

42.1 (37.8-46.5)

41.1 (36.8-45.5)

16.7 (13.6-20.2)

Effectiveness trade-off

30.7 (26.8-34.9)

32.5 (28.5-36.8)

36.6 (32.4-41.03)

OR = 0.609; p = 0.0002

OR = 0.691; p = 0.005

OR = 2.886; p = 0.001

2

No Trade-off

47.5 (43.06-52.09)

39.7 (35.3-44.2)

12.7 (10.01-16.07)

cost trade-off

52.8 (48.3-57.3)

33.7 (29.6-38.1)

13.3 (10.5-16.7)

OR = 1.236; p = 0.103

OR = 0.774; p = 0.058

OR = 1.057; p = 0.771